Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 68

Related Articles by Review for PubMed (Select 17396135)

1.

Potential therapeutic applications of autophagy.

Rubinsztein DC, Gestwicki JE, Murphy LO, Klionsky DJ.

Nat Rev Drug Discov. 2007 Apr;6(4):304-12. Review.

PMID:
17396135
2.

Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies.

Sarkar S, Ravikumar B, Floto RA, Rubinsztein DC.

Cell Death Differ. 2009 Jan;16(1):46-56. doi: 10.1038/cdd.2008.110. Epub 2008 Jul 18. Review.

3.

Targeting autophagic pathways for cancer drug discovery.

Liu B, Bao JK, Yang JM, Cheng Y.

Chin J Cancer. 2013 Mar;32(3):113-20. doi: 10.5732/cjc.012.10010. Epub 2012 Jul 26. Review.

4.

Small molecule enhancers of autophagy for neurodegenerative diseases.

Sarkar S, Rubinsztein DC.

Mol Biosyst. 2008 Sep;4(9):895-901. doi: 10.1039/b804606a. Epub 2008 Jul 4. Review.

PMID:
18704227
5.

Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy.

Tan CC, Yu JT, Tan MS, Jiang T, Zhu XC, Tan L.

Neurobiol Aging. 2014 May;35(5):941-57. doi: 10.1016/j.neurobiolaging.2013.11.019. Epub 2013 Nov 28. Review.

PMID:
24360503
6.

[The two faces of autophagy in the nervous system].

Puyal J, Ginet V, Vaslin A, Truttmann AC, Clarke PG.

Med Sci (Paris). 2009 Apr;25(4):383-90. doi: 10.1051/medsci/2009254383. Review. French.

7.

An expanding role for mTOR in cancer.

Guertin DA, Sabatini DM.

Trends Mol Med. 2005 Aug;11(8):353-61. Review.

PMID:
16002336
8.

Autophagy and misfolded proteins in neurodegeneration.

Metcalf DJ, García-Arencibia M, Hochfeld WE, Rubinsztein DC.

Exp Neurol. 2012 Nov;238(1):22-8. doi: 10.1016/j.expneurol.2010.11.003. Epub 2010 Nov 21. Review.

9.

[Autophagy in cell survival and death].

Codogno P.

J Soc Biol. 2005;199(3):233-41. Review. French.

PMID:
16471263
10.

Autophagy and human diseases.

Jiang P, Mizushima N.

Cell Res. 2014 Jan;24(1):69-79. doi: 10.1038/cr.2013.161. Epub 2013 Dec 10. Review.

11.

Fighting neurodegeneration with rapamycin: mechanistic insights.

Bové J, Martínez-Vicente M, Vila M.

Nat Rev Neurosci. 2011 Jul 20;12(8):437-52. doi: 10.1038/nrn3068. Review.

PMID:
21772323
12.

Core signaling pathways of survival/death in autophagy-related cancer networks.

Wang SY, Yu QJ, Zhang RD, Liu B.

Int J Biochem Cell Biol. 2011 Sep;43(9):1263-6. doi: 10.1016/j.biocel.2011.05.010. Epub 2011 May 26. Review.

PMID:
21640844
13.

[PI3 kinases and the control of autophagia].

Meley D, Pattingre S, Codogno P.

Bull Cancer. 2006 May;93(5):439-44. Review. French.

PMID:
16777620
14.

New targets for therapy in breast cancer: mammalian target of rapamycin (mTOR) antagonists.

Carraway H, Hidalgo M.

Breast Cancer Res. 2004;6(5):219-24. Epub 2004 Aug 12. Review.

15.

Autophagy and neurodegeneration.

He C, Klionsky DJ.

ACS Chem Biol. 2006 May 23;1(4):211-3. Review.

PMID:
17163674
16.

mTOR and cancer therapy.

Easton JB, Houghton PJ.

Oncogene. 2006 Oct 16;25(48):6436-46. Review.

PMID:
17041628
17.

Interplay between histone deacetylases and autophagy--from cancer therapy to neurodegeneration.

Trüe O, Matthias P.

Immunol Cell Biol. 2012 Jan;90(1):78-84. doi: 10.1038/icb.2011.103. Epub 2011 Nov 29. Review.

PMID:
22124372
18.

Autophagy in cancer: good, bad, or both?

Hippert MM, O'Toole PS, Thorburn A.

Cancer Res. 2006 Oct 1;66(19):9349-51. Review.

19.

Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth.

Gibbons JJ, Abraham RT, Yu K.

Semin Oncol. 2009 Dec;36 Suppl 3:S3-S17. doi: 10.1053/j.seminoncol.2009.10.011. Review.

PMID:
19963098
20.

Mechanisms of mTOR inhibitor resistance in cancer therapy.

Carew JS, Kelly KR, Nawrocki ST.

Target Oncol. 2011 Mar;6(1):17-27. doi: 10.1007/s11523-011-0167-8. Epub 2011 Mar 9. Review.

PMID:
21547705
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk